FYR Diagnostics, Inc.
Biotechnology company · Missoula, Montana, United States
FYR Diagnostics, Inc. is a biotechnology company headquartered in Missoula, Montana, United States. Its earliest recorded incorporation is in 2020. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.3 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $8 million sold in a notice filed in 2024.
FYR Diagnostics at a glance
What does FYR Diagnostics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.3 million in total (2019 to 2025). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $8 million sold (2024).
Frequently asked questions about FYR Diagnostics
Where is FYR Diagnostics headquartered?
FYR Diagnostics, Inc. is headquartered in Missoula, Montana, United States.
What does FYR Diagnostics do?
FYR Diagnostics, Inc. is a biotechnology company.
When was FYR Diagnostics founded?
The earliest incorporation on record for FYR Diagnostics, Inc. is in 2020, according to public company registers.
Similar companies
- INIMMUNE CORPorationMissoula, Montana, United States
- Dermaxon LLCMissoula, Montana, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences